WA
UTHR icon

WPG Advisers’s United Therapeutics UTHR Stock Holding History

WPG Advisers’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.8K Sell
90
-17
-16% -$9.57K 0.03% 319
2026
Q1 		$63.4K Sell
107
-2
-2% -$996 0.05% 232
2025
Q4 		$53.1K Sell
109
-128
-54% -$59.6K 0.04% 283
2025
Q3 		$99.4K Sell
237
-19
-7% -$6.39K 0.08% 164
2025
Q2 		$73.6K Buy
256
+62
+32% +$18.5K 0.06% 203
2025
Q1 		$59.8K Sell
194
-19
-9% -$6.51K 0.06% 234
2024
Q4 		$75.2K Buy
+213
New +$78.3K 0.07% 214

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

WPG Advisers's UTHR Position: Q2 2026 in Review

WPG Advisers reduced its United Therapeutics (UTHR) stake by 16% in Q2 2026, selling an estimated $9.57K and leaving 90 shares worth $48.8K. The position accounts for 0.03% of the portfolio, ranked #319.

WPG Advisers first reported a position in UTHR in Q4 2024 and has held it in 7 quarters since. The position peaked at $99.4K in Q3 2025. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • WPG Advisers held 90 shares of United Therapeutics worth $48.8K as of Q2 2026.
  • WPG Advisers sold 17 United Therapeutics shares in Q2 2026, an estimated $9.57K.
  • United Therapeutics made up 0.03% of WPG Advisers's portfolio in Q2 2026, its #319 holding.
  • WPG Advisers first reported a position in United Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's United Therapeutics position peaked at $99.4K in Q3 2025.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.